---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "Wd6Og3teZdfABtW4TvB+qIhzV862KYGQmS6lheULxZ2cCMzRPTZlzvsldxpI600BYEHpzfDhSGxLLfbmmG4nhb9h3j2EJOjONpC7T1tKxtL6t6eqwECNmdEMSK9pTfnT5iS3fdeSh+Qf3rMTeuJhQufjeiLOFlfJ1+EOvIlhPC/EmhNmUNykIkAEtL7KAVUA/yDJmUOx4FAVsoMjD3Y9O4FtAkkEhEImfEcSvxOzgeu3m6dwovNmjjSb8bTyYsGcb/zgTpcxwjq5Zlei+fYdFMkFRHnueQ13a8/Hr8urOak+H4/qLNq6CAjz7qSA6LkL;V2aQ8gLXK/2tkE3z9rXk/Q=="
---

